Nearly 14 million Americans experience vision problems, ranging from the need for glasses to blindness. The National Eye Institute (NEI), part of the National Institutes of Health, supports vision research that leads to sight-saving treatments for these conditions.
This interactive timeline details the research path toward gene therapy treatment for Leber congenital amaurosis (LCA), a blinding genetic condition that affects the eye’s retinal tissue. In a recent NEI-supported study, three young adults with LCA experienced improvements in day and night vision after undergoing gene therapy. The timeline incorporates video interviews with researchers, scientists, and medical experts to trace the scientific process from the laboratory bench to the patient’s bedside.
The National Eye Institute (NEI), a component of the National Institutes of Health, is the federal government’s lead agency for vision research that leads to sight-saving treatments and plays a key role in reducing visual impairment and blindness. For more information, visit the NEI Website at http://www.nei.nih.gov.
The National Institutes of Health (NIH) — The Nation’s Medical Research Agency — includes 27 Institutes and Centers and is a component of the US Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.